Back to search
FDAFDA · Food and drugs·Recall number D-0462-2025

Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90

Published June 18, 2025 · Recall initiated: May 19, 2025

Summary

FDA records drug Class III recall D-0462-2025, published June 18, 2025 and initiated May 19, 2025. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Ongoing; Reported quantity: 6,759 Con - 90 bottle pack; Lot: Lot #: 17240195, Exp 01/31/2026. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.

What to do

Voluntary: Firm initiated · Letter

Get an email if EZETIMIBE AND SIMVASTATIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
EZETIMIBE AND SIMVASTATIN
Manufacturer
Glenmark Pharmaceuticals Inc., USA
Distributor
Nationwide USA and PR
UPC
0368462321300
Lot
Lot #: 17240195, Exp 01/31/2026.
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Ezetimibe and Simvastatin Tablets, 10mg/40mg, 90-count bottle, Rx only, Manufactured by: Glenmark Pharmaceuticals Ltd., Plot No. 2, Phase-2, Pharma Zone SEZ, Madya Pradesh, India, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, NDC 68462-323-90 recalled?

Yes. FDA published recall D-0462-2025 on June 18, 2025. Reported hazard: Failed Impurities/Degradation Specifications: Out of Specification (OOS) for related substances test for Anhydro Simvastatin at the 06-month time point during long-term stability study.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: EZETIMIBE AND SIMVASTATIN. UPC: 0368462321300.